BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7905521)

  • 1. Proliferative response of CD4+ and CD8+ T cell subsets from Hispanics with HIV+ and AIDS: the superantigen hypothesis.
    Eylar EH; Rivera-Quiñones C; Laroche HI; Yamamura Y
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):124-8. PubMed ID: 7905521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
    Gaus H; Miethke T; Wagner H; Heeg K
    Immunology; 1994 Nov; 83(3):333-40. PubMed ID: 7835956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retroviral infection.
    Aoki Y; Hiromatsu K; Usami J; Makino M; Igarashi H; Ogasawara J; Nagata S; Yoshikai Y
    J Immunol; 1994 Oct; 153(8):3611-21. PubMed ID: 7523498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK; Hwang LA; Hui KM
    Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.
    Saloga J; Enk AH; Becker D; Bellinghausen I; Kühn S; Knop J
    Immunology; 1998 Apr; 93(4):485-92. PubMed ID: 9659219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed proliferative response and interleukin-2 production in hispanic HIV+ and AIDS T-cell subsets.
    Eylar EH; Báez I; Vázquez A; Colón-Martínez SL; Yamamura Y
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S25-33. PubMed ID: 8574145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential priming to programmed cell death of superantigen-reactive lymphocytes of HIV patients.
    Gorla R; Imberti L; Prati E; Brugnoni D; Caligaris S; Cattaneo R; Albertini A; Primi D
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1097-103. PubMed ID: 7826697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletion.
    Boyer V; Smith LR; Ferre F; Pezzoli P; Trauger RJ; Jensen FC; Carlo DJ
    Clin Exp Immunol; 1993 Jun; 92(3):437-41. PubMed ID: 8099857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICAM-1 is required for T cell proliferation but not for anergy or apoptosis induced by Staphylococcus aureus enterotoxin B in vivo.
    Gonzalo JA; Martinez C; Springer TA; Gutierrez-Ramos JC
    Int Immunol; 1995 Oct; 7(10):1691-8. PubMed ID: 8562515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cytotoxicity of SEB-activated human PBMC and separated CD8+ and CD4+ T lymphocytes elicited by two different stimulation protocols.
    Seprényi G; Abe J; Kohsaka T
    Immunol Cell Biol; 1996 Dec; 74(6):483-9. PubMed ID: 8989585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1.
    Komanduri KV; Salha MD; Sékaly RP; McCune JM
    J Immunol; 1997 Jan; 158(2):544-9. PubMed ID: 8992966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
    Hashimoto K; Shigeta S; Baba M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
    Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
    Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II.
    Stohl W; Xu D; Zang S; Kim KS; Li L; Hanson JA; Stohlman SA; David CS; Jacob CO
    Int Immunol; 2001 Oct; 13(10):1291-300. PubMed ID: 11581174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
    Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
    Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC).
    Vingerhoets J; Dohlsten M; Penne G; Colebunders R; Sansom D; Bosmans E; Kestens L; Vanham G
    Clin Exp Immunol; 1998 Jan; 111(1):12-9. PubMed ID: 9472656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.